SCHEMBL22493942

SCHEMBL22493942

O=C1[C@H]2C=C[C@H](C2)N1Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EHMT2 Q96KQ7 1/20 0.50
ALDH1A1 P00352 7/20 0.47
TSHR P16473 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
F2 P00734 1/20 0.40
PLG P00747 1/20 0.40
ELANE P08246 1/20 0.40
CTSG P08311 1/20 0.40
CMA1 P23946 1/20 0.40
CTRC Q99895 1/20 0.40
EP300 Q09472 1/20 0.39
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SMO Q99835 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22518781 1.00 EHMT2 (0.50) EHMT2ALDH1A1TSHRSMN1; SMN2CYP3A4
SCHEMBL34469032 1.00 EHMT2 (0.50) EHMT2ALDH1A1TSHRSMN1; SMN2CYP3A4
SCHEMBL34469179 0.80 CMA1 (0.47) ALDH1A1MEN1KMT2ACMA1
SCHEMBL22645696 0.80 CMA1 (0.47) ALDH1A1MEN1KMT2ACMA1
SCHEMBL22645709 0.80 CMA1 (0.47) ALDH1A1MEN1KMT2ACMA1
SCHEMBL20833763 0.80 CMA1 (0.47) ALDH1A1MEN1KMT2ACMA1
SCHEMBL22661096 0.80 CMA1 (0.47) ALDH1A1MEN1KMT2ACMA1
SCHEMBL2079921 0.76 TSHR (0.49) EHMT2ALDH1A1TSHRSMN1; SMN2CYP3A4
SCHEMBL4998470 0.72 SMN1; SMN2 (0.43) ALDH1A1TSHRSMN1; SMN2EP300USP2
SCHEMBL23706931 0.71 ALDH1A1 (0.36) EHMT2ALDH1A1TSHRSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078153-B2 2-difluoro substituted 4-aminocyclopentanecarboxylic acids as inhibitors of gamma-aminobutyric acid aminotransferase and human ornithine aminotransferase NORTHWESTERN UNIVERSITY (US) 2021-08-03 US disclosed
US-20200317606-A1 2-DIFLUORO SUBSTITUTED 4-AMINOCYCLOPENTANECARBOXYLIC ACIDS AS INHIBITORS OF GAMMA-AMINOBUTYRIC ACID AMINOTRANSFERASE AND HUMAN ORNITHINE AMINOTRANSFERASE NORTHWESTERN UNIVERSITY (US) 2020-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078153-B2 2-difluoro substituted 4-aminocyclopentanecarboxylic acids as inhibitors of gamma-aminobutyric acid aminotransferase and human ornithine aminotransferase OAT, OTC, SLC6A13 EHMT2 3930/4885ALDH1A1 169/4885TSHR 2188/4885
US-20200317606-A1 2-DIFLUORO SUBSTITUTED 4-AMINOCYCLOPENTANECARBOXYLIC ACIDS AS INHIBITORS OF GAMMA-AMINOBUTYRIC ACID AMINOTRANSFERASE AND HUMAN ORNITHINE AMINOTRANSFERASE OAT, OTC, SLC6A13 EHMT2 3930/4885ALDH1A1 169/4885TSHR 2188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.